Cohance Lifesciences to meet investors in Singapore, Hong Kong

Cohance Lifesciences Limited, formerly Suven Pharmaceuticals Limited, will participate in the Elara India Conference in Singapore on December 3, 2025, and in Hong Kong on December 4, 2025. These meetings, which include group and one-on-one sessions, are part of the company's engagement with analysts and institutional investors.

The company confirmed that no unpublished price-sensitive information will be disclosed during these interactions. Cohance Lifesciences Limited also noted that the schedule of these meetings is subject to change.

This intimation is made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Kundan Kumar Jha, company secretary, compliance officer, and head-legal, signed the announcement on November 28, 2025.